We hypothesized that satellite cells derived from people with type 2 diabetes would demonstrate a deficient response to IL-6, which could contribute to the metabolic dysfunction of skeletal muscle in type 2 diabetes. Here, IL6 is linked to type 2 diabetes mellitus.